OM:SUS

Stock Analysis Report

Surgical Science Sweden

Executive Summary

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence based laparoscopic and endoscopic training.

Snowflake

Fundamentals

Flawless balance sheet with exceptional growth potential.

Risks

  • Surgical Science Sweden has significant price volatility in the past 3 months.
  • Surgical Science Sweden is covered by less than 3 analysts.

Share Price & News

How has Surgical Science Sweden's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-5.4%

OM:SUS

-3.8%

SE Medical Equipment

-1.3%

SE Market


1 Year Return

289.9%

OM:SUS

14.5%

SE Medical Equipment

-2.7%

SE Market

SUS outperformed the Medical Equipment industry which returned 14.6% over the past year.

SUS outperformed the Market in Sweden which returned -3.1% over the past year.


Share holder returns

SUSIndustryMarket
7 Day-5.4%-3.8%-1.3%
30 Day1.9%-3.0%-4.7%
90 Day79.5%6.8%-2.9%
1 Year289.9%289.9%15.6%14.5%1.4%-2.7%
3 Yearn/a50.3%30.9%25.3%6.6%
5 Yearn/a43.2%24.6%44.9%14.3%

Price Volatility Vs. Market

How volatile is Surgical Science Sweden's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Surgical Science Sweden undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

Surgical Science Sweden's share price is below the future cash flow value, and at a moderate discount (> 20%).

Surgical Science Sweden's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

Surgical Science Sweden is loss making, we can't compare its value to the SE Medical Equipment industry average.

Surgical Science Sweden is loss making, we can't compare the value of its earnings to the Sweden market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Surgical Science Sweden, we can't assess if its growth is good value.


Price Based on Value of Assets

Surgical Science Sweden is overvalued based on assets compared to the SE Medical Equipment industry average.


Next Steps

Future Growth

How is Surgical Science Sweden expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

77.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Surgical Science Sweden's revenue is expected to grow significantly at over 20% yearly.

Surgical Science Sweden's earnings are expected to grow significantly at over 20% yearly.

Surgical Science Sweden's revenue growth is expected to exceed the Sweden market average.

Surgical Science Sweden's earnings growth is expected to exceed the Sweden market average.

Surgical Science Sweden's earnings growth is expected to exceed the low risk savings rate of 0.4%.


Earnings per Share Growth Estimates


Future Return on Equity

Surgical Science Sweden is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).


Next Steps

Past Performance

How has Surgical Science Sweden performed over the past 5 years?

-37.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Surgical Science Sweden does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Surgical Science Sweden's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Surgical Science Sweden's 1-year growth to the SE Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Surgical Science Sweden has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Surgical Science Sweden has efficiently used its assets last year compared to the SE Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Surgical Science Sweden improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Surgical Science Sweden's financial position?


Financial Position Analysis

Surgical Science Sweden is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Surgical Science Sweden's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Surgical Science Sweden has no debt.

Surgical Science Sweden currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet

Low level of unsold assets.

Surgical Science Sweden has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making Surgical Science Sweden has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making Surgical Science Sweden has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 7.7% per year.


Next Steps

Dividend

What is Surgical Science Sweden's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Surgical Science Sweden's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Surgical Science Sweden's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Surgical Science Sweden has not reported any payouts.

Unable to verify if Surgical Science Sweden's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Surgical Science Sweden has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Surgical Science Sweden's salary, the management and board of directors tenure and is there insider trading?

2.6yrs

Average board tenure


CEO

Gisli Hennermark

4.6yrs

Tenure

Mr. Gisli Hennermark serves as Chief Executive Officer of Surgical Science Sweden AB (publ) since 2015. He received MSc from Stockholm School of Economics and Cornell University. He worked previously as a  ...


Board Age and Tenure

2.6yrs

Average Tenure

64yo

Average Age

The average tenure for the Surgical Science Sweden board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Anders Larsson

    Co-Founder & CTO

  • Gisli Hennermark

    Chief Executive Officer

    • Tenure: 4.6yrs
  • Anna Ahlberg (49yo)

    Chief Financial Officer

    • Tenure: 1.6yrs
  • Jan Pedersen (54yo)

    Director of Global Accounts

  • Anders Melander

    Director of Global Sales


Board Members

  • Roland Bengtsson (64yo)

    Chairman of the Board

    • Tenure: 2.6yrs
  • Jan Bengtsson (75yo)

    Director

    • Tenure: 14.6yrs
  • Thomas Eklund (52yo)

    Director

    • Tenure: 2.6yrs
  • Nils Sellbom (60yo)

    Director

    • Tenure: 7.6yrs
  • Tommy Forsell (66yo)

    Director

    • Tenure: 0.6yrs

Company Information

Surgical Science Sweden AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Surgical Science Sweden AB (publ)
  • Ticker: SUS
  • Exchange: OM
  • Founded: 1999
  • Industry: health care equipment
  • Sector: healthcare
  • Market Cap: kr1.762b
  • Shares outstanding: 6.72m
  • Website: Click here

Location

  • Surgical Science Sweden AB (publ)
  • Drakegatan 7 A, 3 tr.
  • Gothenburg
  • Västra Götaland County
  • 412 50
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SUSOM (OMX Nordic Exchange Stockholm)YesShare CapitalSESEKJun 2017

Biography

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim essence, a ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/16 22:19
End of Day Share Price2019/08/16 00:00
Earnings2019/03/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.